{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:52:35Z","timestamp":1790495555359,"version":"4.1.0"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00592","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T06:12:30Z","timestamp":1567145550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":123,"title":["Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice"],"prefix":"10.3389","volume":"10","author":[{"given":"Johan","family":"Kakko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Alho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Baldacchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice Alfonso","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Shaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"B2","volume-title":"World Drug Report 2017","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci Pract Perspect"},{"key":"B4","article-title":"Definitions related to the use of opioids for the treatment of pain","volume":"100","year":"2001","journal-title":"Wisconsin Med J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the brain antireward system","volume":"59","author":"Koob","year":"2008","journal-title":"Annu Rev Psychol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"B8","article-title":"\u201cChapter 10. Diagnosis of Addiction\u201d","volume-title":"The Routledge Handbook of the Philosophy and Science of Addiction","author":"Auriacombe","year":"2017"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06298.x","article-title":"The clinical significance of drug craving","volume":"1248","author":"Tiffany","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"B11","unstructured":"ICD-11: International Classification of Diseases 11th Revision: World Health Organization2018"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-021815-093351","article-title":"The role of craving in substance use disorders: theoretical and methodological issues","volume":"12","author":"Sayette","year":"2016","journal-title":"Annu Rev Clin Psychol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(03)00219-7","article-title":"Definitions related to the medical use of opioids: evolution towards universal agreement","volume":"26","author":"Savage","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nn1105-1442","article-title":"Plasticity of reward neurocircuitry and the \u2018dark side\u2019 of drug addiction","volume":"8","author":"Koob","year":"2005","journal-title":"Nat Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2013.05.001","article-title":"The clinical neurobiology of drug craving","volume":"23","author":"Sinha","year":"2013","journal-title":"Curr Opin Neurobiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1037\/amp0000059","article-title":"Liking, wanting, and the incentive-sensitization theory of addiction","volume":"71","author":"Berridge","year":"2016","journal-title":"Am Psychol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2008.0093","article-title":"Review. The incentive sensitization theory of addiction: some current issues","volume":"363","author":"Robinson","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fpsyt.2013.00179","article-title":"A triadic neurocognitive approach to addiction for clinical interventions","volume":"4","author":"Noel","year":"2013","journal-title":"Front Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/npp.2015.185","article-title":"The human BNST: functional role in anxiety and addiction","volume":"41","author":"Avery","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.31887\/DCNS.2017.19.3\/gkoob","article-title":"Individual differences in the neuropsychopathology of addiction","volume":"19","author":"George","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddmod.2009.04.002","article-title":"Hedonic homeostatic dysregulation as a driver of drug-seeking behavior","volume":"5","author":"Koob","year":"2008","journal-title":"Drug Discovery Today Dis Models"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/10673220490910844","article-title":"Neurobiologic processes in drug reward and addiction","volume":"12","author":"Adinoff","year":"2004","journal-title":"Harv Rev Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.05.024","article-title":"Addiction as a stress surfeit disorder","volume":"76","author":"Koob","year":"2014","journal-title":"Neuropharmacology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.05.005\/","article-title":"Kappa-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2741\/s518","article-title":"Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti-reward systems","volume":"10","author":"Gold","year":"2018","journal-title":"Front Biosci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)90610-4","article-title":"Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro)","volume":"399","author":"Nikolarakis","year":"1986","journal-title":"Brain Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J Neurosci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.125484","article-title":"Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms","volume":"323","author":"Valdez","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0700971","article-title":"The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man","volume":"120","author":"Ur","year":"1997","journal-title":"Br J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2008.01.006","article-title":"Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys","volume":"33","author":"Pascoe","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"B36","article-title":"Urinary excretion and plasma levels of 17-hydroxycorticosteroids during a cycle of addiction to morphine","volume":"132","author":"Eisenman","year":"1961","journal-title":"J Pharmacol Exp Ther"},{"key":"B37","article-title":"Urinary 17-ketosteroid excretion during a cycle of addiction to morphine","volume":"124","author":"Eisenman","year":"1958","journal-title":"J Pharmacol Exp Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(85)90014-6","article-title":"Hypothalamus-pituitary-adrenal axis of heroin addicts","volume":"15","author":"Facchinetti","year":"1985","journal-title":"Drug Alcohol Depend"},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0376-8716(98)00064-7","article-title":"Drug dependence: stress and dysregulation of brain reward pathways","volume":"51","author":"Kreek","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/00952990802013664","article-title":"Serum cortisol secretion during heroin abstinence is elevated only nocturnally","volume":"34","author":"Li","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1992.tb02001.x","article-title":"Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts","volume":"87","author":"Cami","year":"1992","journal-title":"Br J Addict"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/13556210020040235","article-title":"Salivary cortisol during opiate dependence and withdrawal","volume":"6","author":"Bearn","year":"2001","journal-title":"Addict Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/00952990902933878","article-title":"Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts","volume":"35","author":"Shi","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B44","article-title":"Craving by imagery cue reactivity in opiate dependence following detoxification","volume":"45","author":"Behera","year":"2003","journal-title":"Indian J Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2014.04.007","article-title":"Laboratory-induced cue reactivity among individuals with prescription opioid dependence","volume":"39","author":"Back","year":"2014","journal-title":"Addict Behav"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12344","article-title":"Cue-induced craving to paraphernalia and drug images in opioid dependence","volume":"25","author":"McHugh","year":"2016","journal-title":"Am J Addict"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2617-5","article-title":"Drug-related cues exacerbate decision making and increase craving in heroin addicts at different abstinence times","volume":"221","author":"Wang","year":"2012","journal-title":"Psychopharmacol (Berl)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.11.030","article-title":"Cue-induced craving and physiological reactions in recently and long-abstinent heroin-dependent patients","volume":"37","author":"Zhao","year":"2012","journal-title":"Addict Behav"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.275","article-title":"Exacerbated craving in the presence of stress and drug cues in drug-dependent patients","volume":"43","author":"Preston","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.05.015","article-title":"Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals","volume":"70","author":"Fatseas","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0143-4179(84)90081-7","article-title":"ACTH, Cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans","volume":"5","author":"Kreek","year":"1984","journal-title":"Neuropeptides"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.05.001","article-title":"Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence","volume":"63","author":"Kakko","year":"2008","journal-title":"Biol Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300487","article-title":"Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats","volume":"30","author":"Stinus","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2008.00142.x","article-title":"Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats","volume":"14","author":"Greenwell","year":"2009","journal-title":"Addict Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4556-2","article-title":"Don\u2019t stress about CRF: assessing the translational failures of CRF1antagonists","volume":"234","author":"Spierling","year":"2017","journal-title":"Psychopharmacol (Berl)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000200","article-title":"Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin\/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial","volume":"33","author":"Morabbi","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.10.012","article-title":"Selective kappa opioid antagonists for treatment of addiction, are we there yet","volume":"141","author":"Helal","year":"2017","journal-title":"Eur J Med Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/da.22500","article-title":"Kappa-opioid antagonists for psychiatric disorders: from bench to clinical trials","volume":"33","author":"Carlezon","year":"2016","journal-title":"Depress Anxiety"},{"key":"B60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainres.2012.06.024","article-title":"Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: an event-related fMRI study","volume":"1469","author":"Li","year":"2012","journal-title":"Brain Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2009.06.002","article-title":"Clinical and laboratory assessment of the subjective experience of drug craving","volume":"29","author":"Rosenberg","year":"2009","journal-title":"Clin Psychol Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1046\/j.1360-0443.95.8s2.8.x","article-title":"The measurement of drug craving","volume":"95","author":"Sayette","year":"2000","journal-title":"Addiction"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.10.002","article-title":"Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients","volume":"145","author":"McHugh","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"B64","article-title":"The development of a heroin craving questionnaire","author":"Tiffany","year":"1993"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.05.009","article-title":"Heroin and cocaine craving and use during treatment: measurement validation and potential relationships","volume":"31","author":"Heinz","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"B66","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1037\/\/1064-1297.10.1.39","article-title":"Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations","volume":"10","author":"Greenwald","year":"2002","journal-title":"Exp Clin Psychopharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2013.848875","article-title":"Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: a longitudinal study","volume":"40","author":"Tsui","year":"2014","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B68","article-title":"Validation for persian versions of \u201cdesire for drug questionnaire\u201d and \u201cobsessive compulsive drug use scale\u201d in heroin dependents","volume":"19","author":"Hassani-Abharian","year":"2016","journal-title":"Arch Iran Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4603(01)00201-5","article-title":"Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire","volume":"27","author":"Franken","year":"2002","journal-title":"Addict Behav"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.09.014","article-title":"Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients","volume":"144","author":"Garland","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.15.2.134","article-title":"Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment","volume":"15","author":"Hyman","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.11.014","article-title":"Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R)","volume":"9","author":"Butler","year":"2008","journal-title":"J Pain"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12864","article-title":"Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): a proof-of-principle study for customized computer-based testing","volume":"16","author":"Finkelman","year":"2015","journal-title":"Pain Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.024","article-title":"Ecological momentary assessment in the investigation of craving and substance use in daily life: a systematic review","volume":"148","author":"Serre","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"B75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brainresbull.2016.01.012","article-title":"Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence","volume":"123","author":"Huhn","year":"2016","journal-title":"Brain Res Bull"},{"key":"B76","first-page":"13","article-title":"Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology","volume":"31","author":"Moskowitz","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000250","article-title":"Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users","volume":"27","author":"Preston","year":"2016","journal-title":"Behav Pharmacol"},{"key":"B78","unstructured":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims2009"},{"key":"B79","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)2018"},{"key":"B80","first-page":"39","article-title":"Outcomes of opioid-dependence treatment across Europe: identifying opportunities for improvement","volume":"14","author":"Fischer","year":"2012","journal-title":"Heroin Addict Relat Clin Prob"},{"key":"B81","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12888-017-1415-y","article-title":"Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine","volume":"17","author":"Heikman","year":"2017","journal-title":"BMC psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000363232","article-title":"Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment","volume":"21","author":"Soyka","year":"2015","journal-title":"Eur Addict Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2016.1220800","article-title":"Suicidal ideation is associated with individual differences in prescription opioid craving and cue-reactivity among chronic pain patients","volume":"36","author":"Garland","year":"2017","journal-title":"J Addict Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s10865-015-9675-9","article-title":"Thought suppression as a mediator of the association between depressed mood and prescription opioid craving among chronic pain patients","volume":"39","author":"Garland","year":"2016","journal-title":"J Behav Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1017\/S079096670001733X","article-title":"Situational and psycho-social factors associated with relapse following residential detoxification in a population of Irish opioid dependent patients","volume":"29","author":"Ducray","year":"2012","journal-title":"Ir J Psychol Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2012.04.001","article-title":"Mindfulness-based relapse prevention for substance craving","volume":"38","author":"Witkiewitz","year":"2013","journal-title":"Addict Behav"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-4966-9","article-title":"Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder","volume":"235","author":"Preston","year":"2018","journal-title":"Psychopharmacol (Berl)"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.06.010","article-title":"Feasibility and validity of computerized ambulatory monitoring in drug-dependent women","volume":"99","author":"Johnson","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/add.12882","article-title":"Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues","volume":"110","author":"Fatseas","year":"2015","journal-title":"Addiction"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.03.008","article-title":"Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study","volume":"187","author":"Fatseas","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2015.10.001","article-title":"Heroin craving and its correlations with clinical outcome indicators in people with heroin dependence receiving methadone maintenance treatment","volume":"65","author":"Yen","year":"2016","journal-title":"Compr Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03581.x","article-title":"Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders","volume":"107","author":"Tiffany","year":"2012","journal-title":"Addict (Abingdon, Engl)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0899-3289(92)90024-R","article-title":"The relationship between craving, anxiety, and other symptoms in opioid withdrawal","volume":"4","author":"Swift","year":"1992","journal-title":"J Subst Abuse"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4663-0","article-title":"Context and craving during stressful events in the daily lives of drug-dependent patients","volume":"234","author":"Preston","year":"2017","journal-title":"Psychopharmacol (Berl)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2018.1454934","article-title":"Sex differences in daily life stress and craving in opioid-dependent patients","volume":"44","author":"Moran","year":"2018","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugalcdep.2016.06.024","article-title":"Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy","volume":"166","author":"Tsui","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.02.047","article-title":"Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy","volume":"162","author":"Martel","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"B98","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpain.2013.09.014","article-title":"The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving","volume":"15","author":"Martel","year":"2014","journal-title":"J Pain"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12416","article-title":"The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis","volume":"15","author":"Martel","year":"2014","journal-title":"Pain Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318193a6c4","article-title":"Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients","volume":"25","author":"Wasan","year":"2009","journal-title":"Clin J Pain"},{"key":"B101","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13011-018-0160-7","article-title":"Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice","volume":"13","author":"Kakko","year":"2018","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(64)90035-X","article-title":"Conditioned inhibition of craving in drug addiction: a pilot experiment","volume":"3","author":"Wolpe","year":"1965","journal-title":"Behav Res Ther"},{"key":"B103","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3389\/fpsyt.2018.00742","article-title":"Management of opioid addiction with opioid substitution treatments: beyond methadone and buprenorphine","volume":"9","author":"Noble","year":"2019","journal-title":"Front Psychiatry"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2002.tb00235.x","article-title":"Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction","volume":"8","author":"Robinson","year":"2002","journal-title":"CNS Drug Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J Addict Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.jfda.2013.09.037","article-title":"Medication-assisted treatment for opioid addiction: methadone and buprenorphine","volume":"21","author":"Saxon","year":"2013","journal-title":"J Food Drug Anal"},{"key":"B107","unstructured":"Suboxone summary of product charactersitics2016"},{"key":"B108","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/10550887.2010.531672","article-title":"Effect of methadone maintenance treatment on heroin craving, a literature review","volume":"30","author":"Fareed","year":"2011","journal-title":"J Addict Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2010.505991","article-title":"Heroin anticraving medications: a systematic review","volume":"36","author":"Fareed","year":"2010","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2007.04.010","article-title":"Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers","volume":"87","author":"Shi","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N Engl J Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/archpsyc.57.4.395","article-title":"Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance","volume":"57","author":"Preston","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","volume":"144","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00110-X","article-title":"Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study","volume":"23","author":"Zubieta","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1177\/00912709922008236","article-title":"Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations","volume":"39","author":"Nath","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.04.043","article-title":"Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices","volume":"61","author":"Greenwald","year":"2007","journal-title":"Biol Psychiatry"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106060835","article-title":"Naltrexone and buprenorphine combination in the treatment of opioid dependence","volume":"20","author":"Gerra","year":"2006","journal-title":"J Psychopharmacol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"},{"key":"B121","article-title":"\u201cCADTH Rapid Response Reports\u201d","volume-title":"Naltrexone for opioid use disorders: a review of clinical effectiveness, cost-effectiveness, and guidelines","author":"Jahagirdar","year":"2017"},{"key":"B122","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.psyneuen.2009.09.016","article-title":"Acute HPA axis response to naltrexone differs in female vs. male smokers","volume":"35","author":"Roche","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopsych.2010.04.003","article-title":"Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone","volume":"68","author":"Hulse","year":"2010","journal-title":"Biol Psychiatry"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2016.1197231","article-title":"Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant","volume":"42","author":"Krupitsky","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2010.04.012","article-title":"Cognitive behavioral therapy for substance use disorders","volume":"33","author":"McHugh","year":"2010","journal-title":"Psychiatr Clin North Am"},{"key":"B126","article-title":"Motivational interviewing for substance abuse","volume-title":"Cochrane Database Syst Rev","author":"Smedslund","year":"2011"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.05.028","article-title":"Contingency Management interventions for non-prescribed drug use during treatment for opiate addiction: A systematic review and meta-analysis","volume":"178","author":"Ainscough","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/add.12266","article-title":"Comparison of behavioral treatment conditions in buprenorphine maintenance","volume":"108","author":"Ling","year":"2013","journal-title":"Addiction"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/papt.12080","article-title":"Cognitive-behavioural therapy for heroin and cocaine use: Ecological momentary assessment of homework simplification and compliance","volume":"89","author":"Willner-Reid","year":"2016","journal-title":"Psychol Psychother"},{"key":"B130","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3109\/10826084.2013.770027","article-title":"Are mindfulness-based interventions effective for substance use disorders?A systematic review of the evidence","volume":"49","author":"Chiesa","year":"2014","journal-title":"Subst Use Misuse"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000338","article-title":"Mindfulness-based relapse prevention for substance use disorders: a systematic review and meta-analysis","volume":"11","author":"Grant","year":"2017","journal-title":"J Addict Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1159\/000490762","article-title":"The clinical efficacy of mindfulness-based treatments for alcohol and drugs use disorders: a meta-analytic review of randomized and nonrandomized controlled trials","volume":"24","author":"Cavicchioli","year":"2018","journal-title":"Eur Addict Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jsat.2017.01.008","article-title":"Mindfulness treatment for substance misuse: A systematic review and meta-analysis","volume":"75","author":"Li","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"B134","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1037\/pha0000225","article-title":"Autonomic and affective mediators of the relationship between mindfulness and opioid craving among chronic pain patients","volume":"27","author":"Baker","year":"2019","journal-title":"Exp Clin Psychopharmacol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.drugalcdep.2018.03.040","article-title":"Dispositional mindfulness and prescription opioid misuse among chronic pain patients: craving and attention to positive information as mediating mechanisms","volume":"188","author":"Priddy","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1037\/a0035798","article-title":"Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial","volume":"82","author":"Garland","year":"2014","journal-title":"J Consult Clin Psychol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/08897070903250084","article-title":"Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial","volume":"30","author":"Bowen","year":"2009","journal-title":"Subst Abus"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.4546","article-title":"Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial","volume":"71","author":"Bowen","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B139","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jsat.2018.05.002","article-title":"Substance use outcomes for mindfulness based relapse prevention are partially mediated by reductions in stress: results from a randomized trial","volume":"91","author":"Davis","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2012.04.007","article-title":"Effects of mindfulness training on levels of cortisol in cancer patients","volume":"54","author":"Branstrom","year":"2013","journal-title":"Psychosomatics"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(03)00054-4","article-title":"Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients","volume":"29","author":"Carlson","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1159\/000330362","article-title":"Influence of mindfulness practice on cortisol and sleep in long-term and short-term meditators","volume":"65","author":"Brand","year":"2012","journal-title":"Neuropsychobiology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00471","article-title":"Effects of mindfulness-based interventions on salivary cortisol in healthy adults: a meta-analytical review","volume":"7","author":"Sanada","year":"2016","journal-title":"Front Physiol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1097\/00132576-200302030-00001","article-title":"Change in stress levels following mindfulness-based stress reduction in a therapeutic community","volume":"2","author":"Marcus","year":"2003","journal-title":"Addict Disord Treat"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1093\/scan\/nsp034","article-title":"Stress reduction correlates with structural changes in the amygdala","volume":"5","author":"Holzel","year":"2010","journal-title":"Soc Cogn Affect Neurosci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pscychresns.2010.08.006.","article-title":"Mindfulness practice leads to increases in regional brain gray matter density","volume":"191","author":"Holzel","year":"2011","journal-title":"Psychiatry Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00592\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T20:16:32Z","timestamp":1664223392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00592\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":146,"alternative-id":["10.3389\/fpsyt.2019.00592"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00592","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"article-number":"592"}}